Form 8-K - Current report:
SEC Accession No. 0001104659-26-040497
Filing Date
2026-04-07
Accepted
2026-04-07 17:25:26
Documents
12
Period of Report
2026-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2611273d1_8k.htm   iXBRL 8-K 29738
2 EXHIBIT 2.1 tm2611273d1_ex2-1.htm EX-2.1 219277
  Complete submission text file 0001104659-26-040497.txt   468922

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA supn-20260401.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE supn-20260401_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE supn-20260401_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2611273d1_8k_htm.xml XML 3105
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 26845834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)